Hospira Oxaliplatin 5 mg/mL Concentrate for Solution for Infusion, 50 mg/10 mL Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira oxaliplatin 5 mg/ml concentrate for solution for infusion, 50 mg/10 ml

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection - excipient ingredients: tartaric acid; sodium hydroxide; water for injections - oxaliplatin is an anti-cancer drug and is used to treat metastatic (advanced) cancer of the colon (large bowel) or rectum (back passage), or as additional treatment following surgery to remove a tumor (growth) in the colon. it is used in combination with other anti-cancer medicines called 5-fluorouracil (5-fu) and folinic acid (fa).

Hospira Oxaliplatin 5 mg/mL Concentrate for Solution for Infusion, 100 mg/20 mL Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira oxaliplatin 5 mg/ml concentrate for solution for infusion, 100 mg/20 ml

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection - excipient ingredients: water for injections; sodium hydroxide; tartaric acid - oxaliplatin is an anti-cancer drug and is used to treat metastatic (advanced) cancer of the colon (large bowel) or rectum (back passage), or as additional treatment following surgery to remove a tumour (growth) in the colon. it is used in combination with other anti-cancer medicines called 5-fluorouracil (5-fu) and folinic acid (fa).

Hospira Epirubicin Hydrochloride Injection 100 mg/50 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 100 mg/50 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 50 mg/25 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 50 mg/25 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 10 mg/5 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Methotrexate Injection USP 50 mg/2 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira methotrexate injection usp 50 mg/2 ml vial

hospira australia pty ltd - sodium chloride, quantity: 2.6 mg/ml; methotrexate, quantity: 25 mg/ml - injection - excipient ingredients: benzyl alcohol; sodium hydroxide; water for injections; hydrochloric acid - methotrexate injection usp belongs to a group of medicines known as anti-metabolites. it is used in high doses to treat certain types of cancers, including breast cancer, non-hodgkin's lymphoma and leukemia. at lower doses, it may also be used to treat severe psoriasis and severe rheumatoid arthritis.

Hospira Carboplatin Injection 10 mg/mL Solution 50 mg/5 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira carboplatin injection 10 mg/ml solution 50 mg/5 ml vial

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - carboplatin injection is indicated for the treatment of ovarian cancer and small cell lung carcinoma.

Hospira CARBOplatin Injection 50 mg/5 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira carboplatin injection 50 mg/5 ml vial

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - carboplatin injection is indicated for the treatment of ovarian cancer of epithelial origin in first line therapy, and in second line therapy after other treatments have failed.

Hospira Desferrioxamine Mesilate for Injection, BP 500 mg/vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira desferrioxamine mesilate for injection, bp 500 mg/vial

hospira australia pty ltd - desferrioxamine mesilate, quantity: 500 mg - injection, powder for - excipient ingredients: water for injections - a) acute iron intoxication. b) chronic iron overload due to transfusion-dependent anemias. c) diagnosis of aluminium overload (desferrioxamine infusion test). d) chronic aluminium overload in patients with esrf under maintenance dialysis. in cases of acute iron intoxication, desferrioxamine is an adjunct to, and not a substitute for, standard therapeutic measures whuich may include: i) induction of emesis. ii) gastric lavage. iii) maintenance of clear airways. iv) control of peripheral vascular failure. v) correction of acidosis.

Hospira Carboplatin Injection Solution 50 mg/5 mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

hospira carboplatin injection solution 50 mg/5 ml vial

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - carboplatin injection is indicated for the treatment of ovarian cancer and small cell lung carcinoma.